Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05090748 · ClinicalTrials.gov registry record
Study for the Assessment of the Quality of Echocardiographic Clips.
A clinical trial, sponsored by UltraSight.
- Completed
- Registry status
- 240
- Enrollment target
NCT05090748 is a clinical trial that has completed, run by UltraSight. The registered enrollment target is 240 participants.
The verdict
NCT05090748 has completed, sponsored by UltraSight.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, who will perform echocardiography by using UltraSight AI Guidance software, on subjects in the medical centers cardiac units.
Interventions
- DEVICE Echocardiographic.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2022-05-15 |
| Est. Completion | 2022-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05090748
The ClinicalTrials.gov registry entry for NCT05090748 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UltraSight, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Echocardiographic. is the first listed.
NCT05090748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05090748 about?
NCT05090748 is a clinical study titled "Study for the Assessment of the Quality of Echocardiographic Clips.". This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, wh...
What is the current status of trial NCT05090748?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2022-05-15. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT05090748?
The interventions under investigation include: Echocardiographic. (DEVICE).
Who is sponsoring clinical trial NCT05090748?
This trial is sponsored by UltraSight, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.